The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Policies & Impacts

FDA Asks Federal Judge to Protect Access to Abortion Drug Mifepristone

FDA Asks Federal Judge to Protect Access to Abortion Drug Mifepristone
Signage outside of the Food and Drug Administration headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters
Naveen Athrappully
Naveen Athrappully
1/19/2023|Updated: 1/19/2023
0:00

The U.S. Food and Drug Administration (FDA) is asking a federal judge to reject a lawsuit seeking to withdraw the approval given to an abortion drug as plaintiffs accuse the agency of failing to follow proper regulatory standards and succumbing to political machinations during the approval process.

The lawsuit (pdf), filed by a group of pro-life medical doctors and organizations in November, challenges the FDA’s decision to approve the abortion drug mifepristone in 2000.
Naveen Athrappully
Naveen Athrappully
Author
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Author’s Selected Articles

Roblox, Discord Sued Over Alleged Grooming, Kidnapping of 10-Year-Old Girl

Aug 06, 2025
Roblox, Discord Sued Over Alleged Grooming, Kidnapping of 10-Year-Old Girl

US Peak Electricity Demand Breaks Records in July: EIA

Aug 06, 2025
US Peak Electricity Demand Breaks Records in July: EIA

Crypto ATMs Are Targets of Scams and Other Criminal Activity, Treasury Warns

Aug 05, 2025
Crypto ATMs Are Targets of Scams and Other Criminal Activity, Treasury Warns

Semiconductor Giant TSMC Reveals Trade Leaks Involving Employees

Aug 05, 2025
Semiconductor Giant TSMC Reveals Trade Leaks Involving Employees
Related Topics
FDA - Food and Drug Administration
abortion pills
Add to My List
Save
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.